Senior HEOR Analytics & Real-World Evidence Lead

Vertex Pharmaceuticals Incorporated; Boston (MA); Hybrid; USD 172,000 - 258,000; Full time

Job summary

Vertex Pharmaceuticals Incorporated is seeking an Associate Director within HEOR’s Analytics CoE to lead real-world evidence studies using Vertex's in-licensed data assets and support disease/asset teams with observational research, study protocols, and analysis plans.

You will collaborate with statistical programmers and contribute to value strategy, post-hoc analyses, and evidence generation across multiple therapeutic areas.

Qualifications

• 8+ years in health economics and outcomes research.
• Observational research methods applied to real-world data.
• Claims-based analytics using large healthcare datasets.
• SAS programming and Excel proficiency.
• Ability to plan study protocols and analysis plans.
• Strong written and oral communication; cross-functional work.
• Knowledge of national healthcare coding systems.

Responsibilities

• Lead the execution of data queries and analyses with a team.
• Develop study protocols, analysis plans, and table shells.
• Generate analytic reports, tables, and visualizations for stakeholders.
• Collaborate across functions to improve analytics operating model.
• Contribute to internal analytic tools and data quality.
• Support HEOR disease/asset leads in evidence generation objectives.

Skills

Observational research methods

Claims-based analytics

Large healthcare datasets

SAS programming

Excel proficiency

Communication skills

Project planning & management

Analytical reporting & visualization

Education

Advanced degree in health economics or quantitative discipline

Tools

SAS

Excel

Job description

Vertex Pharmaceuticals Incorporated is seeking an Associate Director within HEOR’s Analytics CoE to lead real-world evidence studies using Vertex's in-licensed data assets and support disease/asset teams with observational research, study protocols, and analysis plans.

You will collaborate with statistical programmers and contribute to value strategy, post-hoc analyses, and evidence generation across multiple therapeutic areas.